MTD:NYE-Mettler-Toledo International Inc (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 1254.99

Change

+2.74 (+0.22)%

Market Cap

N/A

Volume

0.13M

Analyst Target

USD 865.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-07 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

+0.90 (+0.38%)

USD 165.08B
A Agilent Technologies Inc

+0.98 (+0.72%)

USD 38.75B
IQV IQVIA Holdings Inc

+3.37 (+1.69%)

USD 36.13B
LH Laboratory Corporation of Amer..

+5.18 (+2.25%)

USD 19.12B
DGX Quest Diagnostics Incorporated

+1.37 (+0.90%)

USD 17.09B
QGEN Qiagen NV

+0.16 (+0.36%)

USD 9.99B
CRL Charles River Laboratories

+0.22 (+0.12%)

USD 9.50B
VNRX Volitionrx Ltd

+0.02 (+3.30%)

USD 0.06B
ENZ Enzo Biochem Inc

-0.02 (-2.64%)

USD 0.04B
TMO Thermo Fisher Scientific Inc

+8.46 (+1.57%)

N/A

ETFs Containing MTD

MCSE Martin Currie Sustainable.. 5.12 % 0.00 %

+0.01 (+0%)

N/A
EPRE 4.58 % 0.00 %

N/A

N/A
IBB iShares Biotechnology ETF 2.56 % 0.47 %

+1.18 (+0%)

USD 6.53B
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.39 % 0.00 %

+0.06 (+0%)

N/A
XMLC:F L&G Clean Water UCITS ETF 2.27 % 0.00 %

N/A

N/A
XLVE:CA 1.82 % 0.00 %

N/A

N/A
HECO SPDR Galaxy Hedged Digita.. 0.00 % 0.95 %

-1.73 (0%)

N/A
QRI:CA 0.00 % 1.06 %

N/A

N/A
ZHU:CA BMO Equal Weight US Healt.. 0.00 % 0.00 %

+0.25 (+0%)

CAD 0.01B
YXM.B:CA 0.00 % 0.69 %

N/A

N/A
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.56% 54% F 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.56% 54% F 83% B
Trailing 12 Months  
Capital Gain 10.01% 92% A 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.01% 85% B 53% F
Trailing 5 Years  
Capital Gain 54.77% 58% F 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 54.77% 50% F 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 14.55% 100% F 74% C
Dividend Return 14.55% 100% F 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 29.61% 38% F 36% F
Risk Adjusted Return 49.15% 85% B 63% D
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.